Featured on New York Times – ‘Could a Smell Test Screen People for Covid?’

Featured on New York Times – ‘Could a Smell Test Screen People for Covid?’

The New York Times article examine our modeling paper on the impact of old factory testing and speak with numerous experts in ENT and infectious disease, digging into how this might help in the pandemic.


In a perfect world, the entrance to every office, restaurant and school would offer a coronavirus test — one with absolute accuracy, and able to instantly determine who was virus-free and safe to admit and who, positively infected, should be turned away.

That reality does not exist. But as the nation struggles to regain a semblance of normal life amid the uncontrolled spread of the virus, some scientists think that a quick test consisting of little more than a stinky strip of paper might at least get us close.

The test does not look for the virus itself, nor can it diagnose disease. Rather, it screens for one of Covid-19’s trademark signs: the loss of the sense of smell. Since last spring, many researchers have come to recognize the symptom, which is also known as anosmia, as one of the best indicators of an ongoing coronavirus infection, capable of identifying even people who don’t otherwise feel sick.



A smell test cannot flag people who contract the coronavirus and never develop any symptoms at all. But in a study that has not yet been published in a scientific journal, a mathematical model showed that sniff-based tests, if administered sufficiently widely and frequently, might detect enough cases to substantially drive transmission down.

Reference: https://www.usmellit.com/featured-on-new-york-times-could-a-smell-test-screen-people-for-covid/

Back to blog